In 2024, the biotech industry will witness significant advancements, with AI playing a larger role in pharmaceutical processes. Through AI, more complex and sophisticated RNA technologies such as mRNAs, miRNAs, and siRNAs will be developed for immunotherapy and disease treatment. Bioprinting technology and tissue engineering are expected to revolutionize organ transplantation, while stem cell technologies aim to advance treatment for chronic diseases. The growing targeted protein degradation market is projected to accelerate drug discovery, while merger and acquisition activity will shape the industry.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
